Publication Date:
1994-04-01
Description:
Transforming growth factor-beta (TGF-beta) and activin exert their effects by binding to heteromeric complexes of type I and type II receptors. The type II receptors for TGF-beta and activin are transmembrane serine-threonine kinases; a series of related receptors, denoted activin receptor-like kinase (ALK) 1 to 5, have recently been identified, and ALK-6 is described here. ALK-5 has been shown to be a functional TGF-beta type I receptor. A systematic analysis revealed that most ALKs formed heteromeric complexes with the type II receptors for TGF-beta and activin after overexpression in COS cells; however, among the six ALKs, only ALK-5 was a functional TGF-beta type I receptor for activation of plasminogen activator inhibitor-1, and only ALK-2 and ALK-4 bound activin with high affinity.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉ten Dijke, P -- Yamashita, H -- Ichijo, H -- Franzen, P -- Laiho, M -- Miyazono, K -- Heldin, C H -- New York, N.Y. -- Science. 1994 Apr 1;264(5155):101-4.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Ludwig Institute for Cancer Research, Uppsala, Sweden.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/8140412" target="_blank"〉PubMed〈/a〉
Keywords:
Activin Receptors
;
Activins
;
Amino Acid Sequence
;
Animals
;
Bone Morphogenetic Protein Receptors, Type I
;
Cell Line
;
Inhibins/*metabolism
;
Ligands
;
Mice
;
Molecular Sequence Data
;
Protein-Serine-Threonine Kinases/chemistry/*metabolism
;
Receptors, Growth Factor/chemistry/*metabolism
;
Receptors, Transforming Growth Factor beta/chemistry/*metabolism
;
Transforming Growth Factor beta/*metabolism
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink